NASDAQ : INSM
Insmed Incorporated — Key statistics
Healthcare · Biotechnology · United States
Last price 112.58 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 24.70B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 24.70B |
| Enterprise Value | 24.28B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 219.38M |
| Shares Outstanding | 219.38M |
| Shares Change (YoY) | +13.67% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 0.62% |
| Owned by Institutions (%) | 104.13% |
| Float | 217.93M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 4,770.34 |
| PS Ratio | 16.25 |
| Forward PS | 9.10 |
| PB Ratio | 34.00 |
| P/TBV Ratio | 52.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 15.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.86 |
| Quick Ratio | 2.36 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -72.45% |
| Return on Assets (ROA) | -17.25% |
| Return on Invested Capital (ROIC) | -25.18% |
| Return on Capital Employed (ROCE) | -38.85% |
| Weighted Average Cost of Capital (WACC) | 8.78% |
| Revenue Per Employee | $913,294 |
| Profits Per Employee | -$363,948 |
| Employee Count | 1,664 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.66 |
Taxes
| Measure | Value |
|---|
| Income Tax | 7.55M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -32.57% |
| 50-Day Moving Average | 112.66 |
| 200-Day Moving Average | 125.42 |
| Relative Strength Index (RSI) | 62.73 |
| Average Volume (20 Days) | 3,745,682 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 13.48M |
| Short Previous Month | 13.80M |
| Short % of Shares Out | 6.14% |
| Short % of Float | 6.18% |
| Short Ratio (days to cover) | 4.85 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.52B |
| Gross Profit | 1.28B |
| Operating Income | -633.13M |
| Pretax Income | -598.06M |
| Net Income | -605.61M |
| EBITDA | -611.03M |
| EBIT | -633.13M |
| Loss Per Share | -$2.80 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 730.94M |
| Net Cash | 415.69M |
| Net Cash Per Share | $1.89 |
| Equity (Book Value) | 726.21M |
| Book Value Per Share | 3.31 |
| Working Capital | 1.11B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -595.62M |
| Capital Expenditures | -31.95M |
| Depreciation & Amortization | 22.09M |
| Net Borrowing | -3.25M |
| Free Cash Flow | -627.58M |
| FCF Per Share | -$2.86 |
Margins
| Measure | Value |
|---|
| Gross Margin | 84.40% |
| Operating Margin | -41.66% |
| Pretax Margin | -39.35% |
| Profit Margin | -39.85% |
| EBITDA Margin | -40.21% |
| EBIT Margin | -41.66% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.67% |
| Shareholder Yield | -13.67% |
| Earnings Yield | -2.49% |
| FCF Yield | -2.54% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $193.95 |
| Price Target Difference | 72.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 86.33% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 3, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 8.99 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |